Request availability and a quotation for your required quantity and destination.
| Product | Tazarotene 0.1% - Tazret Forte Cream 20 g |
|---|---|
| Categories | Skin Care |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Product category: Skin Care
These are different topical retinoids; clinical effects and tolerability depend on the formulation and indication.
Improvement often takes several weeks; individual results vary and follow-up is important.
Redness, dryness, peeling and burning can occur; persistent severe symptoms warrant review.
No. Tazarotene is contraindicated in pregnancy because of fetal risk.
Yes. Minimize UV exposure and use daily sun protection.
Product information updated: 10 October 2026. Educational information supported by the references below; not an individual prescription.
Tazret Forte 0.1% Cream is listed with tazarotene, a prescription topical retinoid. This page explains the ingredient and treatment context; the actual pack and authorised uses must be confirmed.
Important safety information: Tazarotene is contraindicated during pregnancy. Do not start if pregnant or planning pregnancy. People who could become pregnant need clinician-directed pregnancy testing and contraception arrangements before and during treatment.
Tazarotene influences skin-cell development and turnover. Reference tazarotene 0.1% cream labels include acne and plaque psoriasis, but the appropriate indication must be confirmed for the supplied product. An unexplained rash should be diagnosed before using a retinoid.
| Active ingredient | Tazarotene |
|---|---|
| Listed formulation | Tazarotene 0.1% cream; catalogue pack: 20 g |
| Treatment context | Prescription retinoid; acne or plaque-psoriasis use requires diagnosis and local-label confirmation |
The 0.1% concentration does not make tazarotene interchangeable with adapalene 0.1% or tretinoin 0.1%. Treatment choice depends on the medicine, formulation, diagnosis and risk assessment.
Ask which condition is being treated, which skin area to cover and what to do if irritation develops. Do not apply to a new rash or additional body area simply because the medicine was prescribed for another site.
Follow the prescription and actual product leaflet. Apply a thin layer to the directed area after gentle cleansing and drying. Avoid the eyes, lips and mucous membranes. Do not increase the amount or treated surface area without advice.
Burning, stinging, itching, redness and peeling can occur. Your clinician may need to adjust treatment if irritation is excessive. Avoid further application to badly inflamed or damaged skin until you receive advice.
Get prompt medical advice for blistering or severe skin pain. A suspected pregnancy during treatment requires immediate contact with the prescriber. Breathing difficulty or severe allergic swelling requires emergency care.
Review response according to the diagnosed condition. Persistent acne or psoriasis may require a broader plan. Spreading psoriasis, painful skin or joint symptoms warrants medical assessment.
No. Extra product or larger application areas can increase adverse effects. Ask your clinician to review a persistent patch.
The listed active ingredient, tazarotene, is a retinoid rather than a corticosteroid.
No. Tazarotene is contraindicated during pregnancy. Your prescriber must discuss pregnancy testing and effective contraception where applicable.
Not without clinical advice. These medicines and their formulations are different, even when the percentages look similar.
No. Reference labels address plaque psoriasis. The type and extent of disease must be assessed before treatment.
Use these links to understand treatment differences, not to switch or combine medicines without professional advice.
Browse the skincare catalogue for other medicine information.
To enquire about Tazret Forte 0.1% Cream, provide the strength, requested quantity and destination. Cureiva Healthcare will need to confirm the actual manufacturer, pack, stock and applicable prescription and import requirements before supply. This listing does not establish approval in your country or suitability for you.
Enquire about this product · How to enquire and order
References explain the active ingredient and treatment context. A label for another brand does not establish identical excipients, authorised indications or regulatory approval for this product. Follow the supplied leaflet and your clinician’s instructions.